- (-%)
Range - - -   (-%)
Open -
Previous Close 0.440
Buy Price 0.425
Buy Volume 38.9
Sell Price 0.430
Sell Volume 1.3
Volume -
Value -
Measurement Type Value
EPS (SGD) 0.027
Trailing EPS (SGD) 0.023
NAV (SGD) 0.059
Cash In Hand (SGD) 0.061
Dividend 0.023
Dividend Yield (%) 5.213
PE 16.224
Trailing PE 18.838
Price / NAV 7.407
Price / Cash In Hand 7.166
Issued & Paid-up Shares 1,318,055,000
Treasury Shares -
Market Cap (M) 579.944
Par Value (SGD) n.a.
Beta - 75 Days 1.016
R-Squared - 75 Days(%) 7.19
Beta - 500 Days 0.173
R-Squared - 500 Days(%) 0.73
ISIN Code SG2G61000003
Under CPF Investment Scheme (CPFIS) No
Index Components FTSE ST Catalist Index
Delayed prices. Updated at 22 Oct 2020 17:16.
Data powered by
View All Events

About TalkMed

TalkMed Group Limited is a Singapore-based investment holding company. The Company's principal activities are the provision of medical oncology services and stem cell transplant services. The Company's segments include Oncology services and Stem cells services. Its doctors provide tertiary healthcare services in the fields of medical oncology, stem cell transplant and palliative care to the oncology patients in the private sector in Singapore through Parkway Cancer Centre (PCC). Its clinical functions include attending to patients, examination and administering medical treatment to patients and performing minor outpatient surgical procedures, prescribing medicines and investigations, such as laboratory tests or diagnostic procedures. These clinical functions also include the review of investigation results and follow-up care with the patient. It provides medical oncology services and palliative care services with approximately 13 doctors at over eight clinics.

Loading Chart...